אומקור
abbott medical laboratories ltd, israel - omega-3 acid ethyl esters - קפסולות - omega-3 acid ethyl esters 1000 mg - omega-3-triglycerides - omega-3-triglycerides - post myocardial infarction: adjuvant treatment in secondary prevention after myocardial infarction, in addition to other standard therapy (e.g. statins, antiplatelet drugs, betablockers, ace inhibitors). hypertriglyceridaemia: endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response: - type iv hypertriglyceridaemia. - type iib/iii hypertriglyceridaemia in combination with statin, when control of triglycerides by statins is insufficient.
פמאזיר 13.5 מג
medison pharma ltd - pemigatinib - טבליה - pemigatinib 13.5 mg - pemigatinib
פמאזיר 4.5 מג
medison pharma ltd - pemigatinib - טבליה - pemigatinib 4.5 mg - pemigatinib
פמאזיר 9 מג
medison pharma ltd - pemigatinib - טבליה - pemigatinib 9 mg - pemigatinib
גאלאפולד 123 מג
truemed ltd, israel - migalastat as hydrochloride - קפסולה קשיחה - migalastat as hydrochloride 123 mg
טרובלט 50 מ"ג
glaxo smith kline (israel) ltd - retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
טרובלט 50 מ"ג , טרובלט 100 מ"ג
glaxo smith kline (israel) ltd - retigabine 100 mg; retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
טרובלט 100 מ"ג
glaxo smith kline (israel) ltd - retigabine 100 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
טרובלט 300 מ"ג
glaxo smith kline (israel) ltd - retigabine 300 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
טרובלט 400 מ"ג
glaxo smith kline (israel) ltd - retigabine 400 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.